Objective
PREMADES is a medical diagnostic device, developed to provide health care practitioners an objective yet noninvasive
means for the assessment of feeding maturity, by analyzing the swallowing patterns acquired using sensors placed around
their hyoid regions. It is also intended to monitor the improvements by regular measurements and analysis of feeding
maturity in the preterm infants and compare past evaluations. This non-invasive design will be painless for infants and user
friendly for the medical staff.
Currently, in practice, doctors utilize observational, trial-and-error techniques or nursing assessment for identification of
feeding skills in preterm infants, which are mostly subjective. Efforts aimed at more objective assessment techniques have
focused on invasive, pressure measurement methods that can be particularly painful for infants. However, such methods are
not well suited for regular and real-time monitoring of feeding maturity, thus are not preferred in practice.
As a H2020 SME Phase-1 beneficiary, an intensive feasibility study, including market, profitability analyses, possible
improvements required for the prototype and a work plan has been successfully prepared.
PREMADES, will meet a highly important need, particularly in the neonatal medicine. The product is expected to be proper
for point of care usage, marketable globally. Total available market size of our product is €716M/year. According to the
results of our detailed financial feasibility study, we are planning to achieve €67M revenue creating a total of 65 new jobs at
the end of the fourth year.
In Phase-2, further technical improvements will be made on the prototype and intensive commercialization activities will be
implemented. To ensure a successful entrance and fast penetration into the European markets, the outcomes of the Phase 1
studies will be carefully used in Phase 2, which will help in terms of the design, production and marketing procedures to be
conducted in a right manner.
Fields of science
Programme(s)
Topic(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
06800 CANKAYA ANKARA
Türkiye
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.